Purple Biotech
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -53 | -58 | -47 | -45 |
EBITDA | -23,592 | -1,247 | -1,042 | -376 |
EBIT | -23,645 | -1,306 | -1,089 | -421 |
Net Income | -23,887 | -1,309 | -1,085 | -453 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,070 | -1,065 | -1,546 | -1,978 |
Cash | 8,716 | 9,592 | 4,736 | 5,772 |
Basic Shares | 2 | 284 | 273 | 263 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $195 | $-910 |
Gross Profit | -204 | -186 | ||
EBITDA | -27,675 | -7,052 | -19,875 | -21,492 |
EBIT | -27,880 | -7,238 | -19,921 | -21,693 |
Net Income | -26,809 | -7,240 | -19 | -21,668 |
Net Change In Cash | 0 | 0 | 195 | -910 |
Free Cash Flow | -5,539 | -14,367 | -19,928 | -16,963 |
Cash | 8,716 | 7,401 | 14,489 | 15,030 |
Basic Shares | 2 | 163 | 110 | 90 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$49.35 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.40 |
2025-03-31 | -$0.17 |
